The Motley Fool

Key Data Points

Primary metrics and data points about ImmunoGen.
Current Price: $16.67
Prev Close: $18.02
Open: $17.18
Bid: $16.70
Ask: $16.73
Day's Range: $16.34 - $17.54
52wk Range: $5.34 - $19.43
Volume: 1,118,792
Avg Vol 1,299,820
Market Cap: $1B
P/E (ttm): -27.72
EPS (ttm): ($0.65)
Div & Yield: $0.00 (0.0%)

News and Headlines

Latest news about ImmunoGen from Fool.com.

Business Summary

Industry, sector and description for ImmunoGen.

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

IMGN vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about ImmunoGen.
CAPS Rating 3 out of 5
 
334 Outperform
26 Underperform
CAPS All Stars
 
81 Outperform
6 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Dan Junius, CEO

71% Approve

Based on 8 Ratings

More Details for ImmunoGenJobs

Powered by

More Details about ImmunoGen

Primary metrics and data points about ImmunoGen.